Peg-interfon alpha-2a and low-dose ribavirin for treatment of hepatitis C virus infection in patients with sickle-cell anemia in Saudi Arabia

BACKGROUND AND OBJECTIVES: Data regarding the safety and efficacy of antiviral therapy with pegylated interferon (PEG-IFN) and ribavirin (RBV) in patients with sickle-cell disease (SCD) and hepatitis C virus (HCV) infection are scanty. In this study, our aim was to evaluate the safety and efficacy o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Saudi Med
Autors principals: Agha, Adnan, Chakik, Rafaat, Abdulhadi Ali, Mamdouh M., Alsaudi, Dib, Sammito, Giorgio, Giannini, Edoardo Giovanni
Format: Artigo
Idioma:Inglês
Publicat: King Faisal Specialist Hospital and Research Centre 2013
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6074907/
https://ncbi.nlm.nih.gov/pubmed/24413867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5144/0256-4947.2013.610
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars